7779 Cyberdyne
- 197
- -8-3.90%
Cyberdyne News
Cyberdyne: Consolidated financial statements (Tan Shin) for the three months ending June 30, 2025 (based on IFRS).
Cyberdyne: 2025 Fiscal Year March Quarter Financial Results Short Message [IFRS] (Consolidated)
Cyberdyne: Regarding matters related to dominant shareholders.
Cyberdyne: Explanatory material about business plans and growth potential.
Cyberdyne: Report on Corporate Governance, June 28th, 2024.
Cyberdyne: Interim report
Cyberdyne: Announcements of individual stocks regarding the selection of projects to support research and development of growing small and medium-sized enterprises.
Cyberdyne: Announcements of individual stocks: Notice of adoption of the Growth-Oriented Small and Medium-sized Enterprise Research and Development Support Program (Go-Tech Program) in FY 2024.
Cyberdyne: Financial Report - 20th Term (2023/04/01 - 2024/03/31)
Cyberdyne: Internal Control Report - Term 20 (2023/04/01 - 2024/03/31)
Cyberdyne: Confirmation letter
Cyberdyne: Independent Company Executives Declaration
Cyberdyne: Notice of the 20th Annual General Meeting of Shareholders (matters not included in submitted documents)
Cyberdyne: Notice of the 20th Annual General Meeting of Shareholders
Cyberdyne: Documents of the 20th Annual General Meeting of Shareholders (matters not described in issued documents)
Cyberdyne: Notice of Convocation of the 20th Annual General Meeting of Shareholders and Shareholders' Meeting Materials
Cyberdyne: Preparations are underway for Malaysia's National Neurorobotics Cybernics Rehabilitation Centre
Cyberdyne: Preparations for the Malaysian National Neurorobotics Cybernics Rehabilitation Center are progressing ~ Minister of Human Resources visits the company and expresses intention to introduce HAL on a large scale ~
Cyberdyne: The US FDA approved for the first time in the world a small model of medical HAL and expanded indications for cerebral palsy
Cyberdyne: Notifications about financial income, financial expenses, extraordinary losses, and differences in financial results between the previous fiscal year and the current fiscal year
Analysis
Price Target
No Data
